Manual-based Art Therapy for Adolescents With Depression

October 20, 2020 updated by: Christina Blomdahl, Vastra Gotaland Region

Manual-based Art Therapy for Adolescents With Depression: a Pilot Study in Child and Youth Psychiatric Clinic in Sweden

There is a need to evaluate different interventions in order to meet young people's needs of treatment. The study's goal is to find out if manual-based art therapy is a useful method for young people with depression and thus increase the availability of methods of treatment for adolescents with depression in Child and youth psychiatry in Sweden.

The aim is to investigate whether manual-based art therapy is useful as treatment for adolescents with depression by examining feasibility, acceptability and compliant to treatment. Secondary, preliminary study of adolescent depressive symptoms, quality of life and functional level is affected by the treatment.

Method: Data from youths aged 13-17 years old and their parents will be collected with questionnaires and structured interviews. Measurements are taken before and after treatment. Acceptability and feasibility will be examined by participants' presence, drop out and cancellations and also by checking the art therapists' compliance to the manual and investigate their reasons to diverge from the manual

Study Overview

Status

Completed

Study Type

Interventional

Enrollment (Actual)

10

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Västra Götaland
      • Borås, Västra Götaland, Sweden, 50182
        • Sodra Alvsborgs Hospital

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

13 years to 17 years (CHILD)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • Age 13-17 year
  • Depression as main diagnosis

Exclusion Criteria:

  • high suicide risk
  • ongoing psychosis
  • eating disorder
  • Untreated PTSD
  • Patients are excluded if there is suspicion of violence, abuse, abuse in the home or other vulnerability which requires other interventions to ensure the safety.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: TREATMENT
  • Allocation: NA
  • Interventional Model: SINGLE_GROUP
  • Masking: NONE

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
EXPERIMENTAL: Intervention
This is a quasi-experimental study
This is a manual-based treatment and consists of 10 one-hour weekly sessions. The treatment consist of detailed guidelines based on phenomenological art therapy. The sessions follow the same structure: Introduction, short relaxation, art-making, reflections about the image, and conclusions. Examples of comprised art tasks; lifeline, emotional scribbles, and different roles. The art tasks served as a prompt for painting.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Adherence to manual - therapists
Time Frame: 10 weeks
the therapists self-rate their compliance to the manual on a 4 point Likert scale. describing reasons to adverting from manual
10 weeks
Change of Treatment satisfaction
Time Frame: Change from baseline at 10 weeks
Level of satisfactions rated on a 5 point Likert scale. Higher scores indicates higher satisfaction.
Change from baseline at 10 weeks

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Change of Depression with Beck Depression Inventory BDI-II
Time Frame: Change from baseline at 10 weeks
contains 21 questions, each answer being scored on a scale value of 0 to 3. Higher score indicate more severe depression.
Change from baseline at 10 weeks
Change of quality of life measured with KIDSCREEN-10
Time Frame: Change from baseline at 10 weeks
Measure global Health related quality of life. HRQoL score for monitoring and screening uses. the questionnaire consist of 10 questions, each answer being scored on a 5 points Likert scale.
Change from baseline at 10 weeks
Change of functional impairment measured with Education,Work and Social adjustment Scale EWSAS-C/P
Time Frame: Change from baseline at 10 weeks
Is a self-reported scale to measure functional impairment attributed to an identified problem. is a five-item self-report scale measuring functional impairment on a nine-point scale. Higher rating indicating more impairment.
Change from baseline at 10 weeks
Change of psychiatric symptoms measured with Revised Children's Anxiety and Depression Scale /R-CADS
Time Frame: Change from baseline at 10 weeks
47-item questionnaires that measure the reported frequency of various symptoms of anxiety and low mood. They produce a total anxiety and low mood score and separate scores for each of the follow sub-scales: separation anxiety; social phobia; generalized anxiety; panic; obsessive compulsive; total anxiety; and, low mood. Each answer being scored on a 4 points Likert scale.
Change from baseline at 10 weeks

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Christina Blomdahl, PhD, Region Vastra Gotaland, Sweden

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (ACTUAL)

January 1, 2019

Primary Completion (ACTUAL)

October 8, 2020

Study Completion (ACTUAL)

October 8, 2020

Study Registration Dates

First Submitted

June 29, 2020

First Submitted That Met QC Criteria

October 20, 2020

First Posted (ACTUAL)

October 26, 2020

Study Record Updates

Last Update Posted (ACTUAL)

October 26, 2020

Last Update Submitted That Met QC Criteria

October 20, 2020

Last Verified

October 1, 2020

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Depressive Disorder

Clinical Trials on Manual-based Art Therapy

3
Subscribe